Cargando…
Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470905/ http://dx.doi.org/10.1192/j.eurpsy.2021.258 |
_version_ | 1784788944088465408 |
---|---|
author | Gaete, J. Ramirez, S. Gana, S. Godoy, M. Valenzuela, M. |
author_facet | Gaete, J. Ramirez, S. Gana, S. Godoy, M. Valenzuela, M. |
author_sort | Gaete, J. |
collection | PubMed |
description | INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population. OBJECTIVES: To evaluate the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap). METHODS: A cross-sectional study was carried out in 13 schools in Santiago of Chile. The sample included 2,261 adolescents of 10 to 14 years old. The linguistic and cultural adaptation was conducted using focus groups, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood by adolescents. Regarding the subscales of risk and protective factors, they needed some changes, and once completed, all new subscales had good or adequate goodness of fit adjustment. Regarding reliability, all of the new subscales had good or acceptable internal consistency according to the omega coefficient (range from 0.69 to 0.89). Finally, most of the risk and protective factors measured by the questionnaire were strongly associated with different substance use outcomes, especially those related to positive and negative beliefs or attitudes towards drugs, normative beliefs, and refusal skills. CONCLUSIONS: The current findings suggest that the EU-Dap questionnaire is a valid and reliable instrument, and it may help to evaluate the effectiveness of preventive interventions in the future. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9470905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94709052022-09-29 Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile Gaete, J. Ramirez, S. Gana, S. Godoy, M. Valenzuela, M. Eur Psychiatry Abstract INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population. OBJECTIVES: To evaluate the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap). METHODS: A cross-sectional study was carried out in 13 schools in Santiago of Chile. The sample included 2,261 adolescents of 10 to 14 years old. The linguistic and cultural adaptation was conducted using focus groups, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood by adolescents. Regarding the subscales of risk and protective factors, they needed some changes, and once completed, all new subscales had good or adequate goodness of fit adjustment. Regarding reliability, all of the new subscales had good or acceptable internal consistency according to the omega coefficient (range from 0.69 to 0.89). Finally, most of the risk and protective factors measured by the questionnaire were strongly associated with different substance use outcomes, especially those related to positive and negative beliefs or attitudes towards drugs, normative beliefs, and refusal skills. CONCLUSIONS: The current findings suggest that the EU-Dap questionnaire is a valid and reliable instrument, and it may help to evaluate the effectiveness of preventive interventions in the future. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470905/ http://dx.doi.org/10.1192/j.eurpsy.2021.258 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Gaete, J. Ramirez, S. Gana, S. Godoy, M. Valenzuela, M. Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title | Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title_full | Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title_fullStr | Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title_full_unstemmed | Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title_short | Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile |
title_sort | validation of the european drug addiction prevention trial questionnaire (eu-dap) for substance use screening and to assess risk and protective factors among adolescents in chile |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470905/ http://dx.doi.org/10.1192/j.eurpsy.2021.258 |
work_keys_str_mv | AT gaetej validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile AT ramirezs validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile AT ganas validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile AT godoym validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile AT valenzuelam validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile |